Citations (136)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Fereshteh Ansari, Shohre Alian Samakkhah, Ali Bahadori, Seyedeh Maedeh Jafari, Mojtaba Ziaee, Mohammad Taghi Khodayari & Hadi Pourjafar. (2023) Health-promoting properties of Saccharomyces cerevisiae var. boulardii as a probiotic; characteristics, isolation, and applications in dairy products. Critical Reviews in Food Science and Nutrition 63:4, pages 457-485.
Read now
Read now
Jin Imai, Sho Kitamoto & Nobuhiko Kamada. (2021) The pathogenic oral–gut–liver axis: new understandings and clinical implications. Expert Review of Clinical Immunology 17:7, pages 727-736.
Read now
Read now
Chloe Terciolo, Michel Dapoigny & Frederic Andre. (2019) Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption. Clinical and Experimental Gastroenterology 12, pages 67-82.
Read now
Read now
Kavitha Sivananthan & Andreas Munk Petersen. (2018) Review of Saccharomyces boulardii as a treatment option in IBD. Immunopharmacology and Immunotoxicology 40:6, pages 465-475.
Read now
Read now
Amir Saber, Beitollah Alipour, Zeinab Faghfoori & Ahmad Yari Khosroushahi. (2017) Cellular and molecular effects of yeast probiotics on cancer. Critical Reviews in Microbiology 43:1, pages 96-115.
Read now
Read now
Yezaz A Ghouri, David M Richards, Erik F Rahimi, Joseph T Krill, Katherine A Jelinek & Andrew W DuPont. (2014) Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clinical and Experimental Gastroenterology 7, pages 473-487.
Read now
Read now
Ener Cagri Dinleyici, Ates Kara, Metehan Ozen & Yvan Vandenplas. (2014) Saccharomyces boulardii CNCM I-745 in different clinical conditions. Expert Opinion on Biological Therapy 14:11, pages 1593-1609.
Read now
Read now
John K Triantafillidis, Emmanuel Merikas & Filippos Georgopoulos. (2011) Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Design, Development and Therapy 5, pages 185-210.
Read now
Read now
Stefano Guandalini. (2010) Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Review of Clinical Immunology 6:1, pages 47-54.
Read now
Read now
Lars Aabakken. (2008) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:7, pages 771-773.
Read now
Read now
Articles from other publishers (126)
Yueying Ma, Dandan Yang, Jin Huang, Kunli Liu, Huirong Liu, Huangan Wu & Chunhui Bao. (2024) Probiotics for inflammatory bowel disease: Is there sufficient evidence?. Open Life Sciences 19:1.
Crossref
Crossref
Siyu Wang, Shuwei Zhou, Zhongyu Han, Bin Yu, Yin Xu, Yumeng Lin, Yutong Chen, Zi Jin, Yalong Li, Qinhan Cao, Yunying Xu, Qiang Zhang & Yuan-Cheng Wang. (2024) From gut to brain: understanding the role of microbiota in inflammatory bowel disease. Frontiers in Immunology 15.
Crossref
Crossref
Swapna Vijayan, Venkataramana Kandi, Pratyusha S Palacholla, Reshma Rajendran, Chandrasagar Jarugu, Jayashankar CA, Mundla Pravallika, Shruthi C Reddy & Atul S Sucharitha. (2024) Probiotics in Allergy and Immunological Diseases: A Comprehensive Review. Cureus.
Crossref
Crossref
Amit Yadav, Renu Yadav, Vishal Sharma & Usha Dutta. (2024) A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease. Indian Journal of Gastroenterology 43:1, pages 112-128.
Crossref
Crossref
Keila Rodrigues Zanardi, Mariana Grancieri, Caroline Woelffel Silva, Leonardo Oliveira Trivillin, Mirelle Lomar Viana, André Gustavo Vasconcelos Costa & Neuza Maria Brunoro Costa. (2023)
Functional effects of yacon (
Smallanthus sonchifolius
) and kefir on systemic inflammation, antioxidant activity, and intestinal microbiome in rats with induced colorectal cancer
. Food & Function 14:19, pages 9000-9017.
Crossref
Crossref
Qihui Li, Tenghui Zheng, Hanting Ding, Jiaming Chen, Baofeng Li, Qianzi Zhang, Siwang Yang, Shihai Zhang & Wutai Guan. (2023) Exploring the Benefits of Probiotics in Gut Inflammation and Diarrhea—From an Antioxidant Perspective. Antioxidants 12:7, pages 1342.
Crossref
Crossref
Nathalie Ballet, Sarah Renaud, Hugo Roume, Fanny George, Pascal Vandekerckove, Mickaël Boyer & Mickaël Durand-Dubief. (2023) Saccharomyces cerevisiae: Multifaceted Applications in One Health and the Achievement of Sustainable Development Goals. Encyclopedia 3:2, pages 602-613.
Crossref
Crossref
Xue Fang, Le Kang, Yi-Fan Qiu, Zhao-Shen Li & Yu Bai. (2023) Yersinia enterocolitica in Crohn’s disease. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Amélie Lê, Marine Mantel, Justine Marchix, Marie Bodinier, Gwénaël Jan & Malvyne Rolli-Derkinderen. (2022) Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?. American Journal of Physiology-Gastrointestinal and Liver Physiology 323:6, pages G523-G553.
Crossref
Crossref
Jaqueline Maciel Vieira Theodoro, Mariana Grancieri, Mariana Juste Contin Gomes, Renata Celi Lopes Toledo, Vinícius Parzanini Brilhante de São José, Hilário Cuquetto Mantovani, Carlos Wanderlei Piler Carvalho, Bárbara Pereira da Silva & Hércia Stampini Duarte Martino. (2022) Germinated Millet (Pennisetum glaucum (L.) R. Br.) Flour Improved the Gut Function and Its Microbiota Composition in Rats Fed with High-Fat High-Fructose Diet. International Journal of Environmental Research and Public Health 19:22, pages 15217.
Crossref
Crossref
Oscar David Medina Martinez, Mariana Juste Contin Gomes, Mariana Grancieri, Vinícius Parzanini Brilhante de São José, Renata Celi Lopes Toledo, Valéria Aparecida Vieira Queiroz, Bárbara Pereira da Silva & Hércia Stampini Duarte Martino. (2022) Sorghum flour BRS 305 hybrid has the potential to modulate the intestinal microbiota of rats fed with a high-fat high-fructose diet. European Journal of Nutrition.
Crossref
Crossref
Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH & Seckin Bahar SEZGINOzgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH & Seckin Bahar SEZGIN. 2022. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine
106
164
.
Raffaella Maria Gadaleta, Marica Cariello, Lucilla Crudele & Antonio Moschetta. (2022) Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”. Nutrients 14:15, pages 3212.
Crossref
Crossref
Kyung Jae LeeEell Ryoo, Yoo Min Lee, Jung Min Yoon, Hyo-Jeong Jang, So Yoon Choi, You Jin Choi, Hyun Jin Kim, Ju Young Chung & Jung Ok Shim. (2022)
Saccharomyces boulardii
and Lactulose for Childhood Functional Constipation: A Multicenter Randomized Controlled Trial
. Journal of Neurogastroenterology and Motility 28:3, pages 454-462.
Crossref
Crossref
Gina L Guzzo, Jane M Andrews & Laura S Weyrich. (2022) The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 28:7, pages 1112-1122.
Crossref
Crossref
Nermin Kamal Saeed, Mohammed Al-Beltagi, Adel Salah Bediwy, Yasser El-Sawaf & Osama Toema. (2022) Gut microbiota in various childhood disorders: Implication and indications. World Journal of Gastroenterology 28:18, pages 1875-1901.
Crossref
Crossref
Kamilla Pontes Azevedo, Maria Zilda de Jesus Catulio, Rávila Graziany Machado de Souza & Maria Luiza Ferreira Stringhini. (2022) Probiotics in Crohn's disease remission: a systematic review. Archivos Latinoamericanos de Nutrición 72:1, pages 50-59.
Crossref
Crossref
Rameesha Abid, Hassan Waseem, Jafar Ali, Shakira Ghazanfar, Ghulam Muhammad Ali, Abdelbaset Mohamed Elasbali & Salem Hussain Alharethi. (2022) Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health. Journal of Fungi 8:5, pages 444.
Crossref
Crossref
Jonathan Gan, Scarlet Nazarian, Julian Teare, Ara Darzi, Hutan Ashrafian & Alex J. Thompson. (2022) A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn’s disease. BMC Gastroenterology 22:1.
Crossref
Crossref
Diego Cabral Lacerda, Paulo César Trindade da Costa, Luciana Caroline Paulino do Nascimento & José Luiz de Brito Alves. 2022. Probiotics for Human Nutrition in Health and Disease. Probiotics for Human Nutrition in Health and Disease
431
448
.
Yashar Houshyar, Luca Massimino, Luigi Antonio Lamparelli, Silvio Danese & Federica Ungaro. (2021) Going Beyond Bacteria: Uncovering the Role of Archaeome and Mycobiome in Inflammatory Bowel Disease. Frontiers in Physiology 12.
Crossref
Crossref
Rachel M Presti, Eunice Yeh, Brett Williams, Alan Landay, Jeffrey M Jacobson, Cara Wilson, Carl J Fichtenbaum, Netanya S Utay, Michael P Dube, Karin L Klingman, Jacob D Estes, Jacob K Flynn, Amanda Loftin, Jason M Brenchley, Adriana Andrade, Douglas W Kitch & Edgar T Overton. (2021) A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy. Open Forum Infectious Diseases 8:12.
Crossref
Crossref
Adeline Sivignon, Shin-Yi Yu, Nathalie Ballet, Pascal Vandekerckove, Nicolas Barnich & Yann Guerardel. (2021) Heteropolysaccharides from S. cerevisiae show anti-adhesive properties against E. coli associated with Crohn's disease. Carbohydrate Polymers 271, pages 118415.
Crossref
Crossref
Shinya Sato, Tadashi Namisaki, Koji Murata, Yuki Fujimoto, Soichi Takeda, Masahide Enomoto, Akihiko Shibamoto, Koji Ishida, Hiroyuki Ogawa, Hirotetsu Takagi, Yuki Tsuji, Daisuke Kaya, Yukihisa Fujinaga, Masanori Furukawa, Takashi InoueYasuhiko Sawada, Norihisa Nishimura, Koh Kitagawa, Takahiro Ozutsumi, Hiroaki Takaya, Kosuke Kaji, Naotaka Shimozato, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Akira Mitoro & Hitoshi Yoshiji. (2021) The association between sarcopenia and endotoxin in patients with alcoholic cirrhosis. Medicine 100:36, pages e27212.
Crossref
Crossref
Alexander S. Dowdell & Sean P. Colgan. (2021) Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD). Pharmaceuticals 14:8, pages 708.
Crossref
Crossref
Marjo J. E. Campmans-Kuijpers & Gerard Dijkstra. (2021) Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID). Nutrients 13:4, pages 1067.
Crossref
Crossref
Mahdi Shadnoush, Maryam Nazari, Hossein Hajianfar & Zeinab Faghfoori. (2021) Effects of probiotic yogurt consumption on intestinal permeability in inflammatory bowel disease: A double-blind randomized clinical Trial. Koomesh journal 23:2, pages 211-217.
Crossref
Crossref
Thalita Lin Netto Cândido, Laís Emilia da Silva, Flávia Galvão Cândido, Flávia Xavier Valente, Juliana Soares da Silva, Déborah Romaskevis Gomes Lopes, Maria do Carmo Gouveia Peluzio, Hilário Cuquetto Mantovani & Rita de Cássia Gonçalves Alfenas. (2021) Effect of the ingestion of vegetable oils associated with energy-restricted normofat diet on intestinal microbiota and permeability in overweight women. Food Research International 139, pages 109951.
Crossref
Crossref
Priyanka Devi, Yerramsetti Nanaji, Nikita Khanna, Ashok Kumar Yadav & Sandip V. Pawar. 2021. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics
85
121
.
Gyu Man Oh, Won Moon, Kwang Il Seo, Kyoungwon Jung, Jae Hyun Kim, Sung Eun Kim, Moo In Park & Seun Ja Park. (2020)
Changes in the Crohn’s Disease Activity Index and Safety of Administering
Saccharomyces Boulardii
in Patients with Crohn’s Disease in Clinical Remission: A Single Hospital-based Retrospective Cohort Study
. The Korean Journal of Gastroenterology 76:6, pages 314-321.
Crossref
Crossref
Lakshya Sharma & Antonio Riva. (2020) Intestinal Barrier Function in Health and Disease—Any Role of SARS-CoV-2?. Microorganisms 8:11, pages 1744.
Crossref
Crossref
Ching-Yen Lin, Anne H Lee, Karen K Chiu, Miranda D Vieson, Andrew J Steelman & Kelly S Swanson. (2020) Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model. Current Developments in Nutrition 4:11, pages 4011006.
Crossref
Crossref
Antonio Benítez-Cabello, Edgar Torres-Maravilla, Luis Bermúdez-Humarán, Philippe Langella, Rebeca Martín, Rufino Jiménez-Díaz & Francisco Noé Arroyo-López. (2019) Probiotic Properties of Lactobacillus Strains Isolated from Table Olive Biofilms. Probiotics and Antimicrobial Proteins 12:3, pages 1071-1082.
Crossref
Crossref
Gang Wang, Shuo Huang, Shuang Cai, Haitao Yu, Yuming Wang, Xiangfang Zeng & Shiyan Qiao. (2020) Lactobacillus reuteri Ameliorates Intestinal Inflammation and Modulates Gut Microbiota and Metabolic Disorders in Dextran Sulfate Sodium-Induced Colitis in Mice. Nutrients 12:8, pages 2298.
Crossref
Crossref
Rong Lu, Mei Shang, Yong-Guo Zhang, Yang Jiao, Yinglin Xia, Shari Garrett, Danika Bakke, Christine Bäuerl, Gaspar Perez Martinez, Cheol-Hyun Kim, Sang-Moo Kang & Jun Sun. (2020) Lactic Acid Bacteria Isolated From Korean Kimchi Activate the Vitamin D Receptor–autophagy Signaling Pathways. Inflammatory Bowel Diseases 26:8, pages 1199-1211.
Crossref
Crossref
Dominika Jakubczyk, Katarzyna Leszczyńska & Sabina Górska. (2020) The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review. Nutrients 12:7, pages 1973.
Crossref
Crossref
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova & E. V. Shikh. (2020) Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii. Meditsinskiy sovet = Medical Council:5, pages 104-112.
Crossref
Crossref
Natália Oliveira e Silva, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Maria Luísa Cordeiro Santos & Fabrício Freire de Melo. (2020) Probiotics in inflammatory bowel disease: Does it work?. World Journal of Meta-Analysis 8:2, pages 54-66.
Crossref
Crossref
Stephan C. Bischoff, Johanna Escher, Xavier Hébuterne, Stanisław Kłęk, Zeljko Krznaric, Stéphane Schneider, Raanan Shamir, Kalina Stardelova, Nicolette Wierdsma, Anthony E. Wiskin & Alastair Forbes. (2020) ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease. Clinical Nutrition 39:3, pages 632-653.
Crossref
Crossref
Elena Hadjimbei, George Botsaris, Vlasios Goulas, Eleni Alexandri, Vassilis Gekas & Ioannis P Gerothanassis. (2019)
Functional stability of goats' milk yoghurt supplemented with
Pistacia atlantica
resin extracts and
Saccharomyces boulardii
. International Journal of Dairy Technology 73:1, pages 134-143.
Crossref
Crossref
Corene Humphreys. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
166
177.e4
.
Barbora Pipek. (2019) Inflammatory bowel disease and the importance of probiotics treatment. Medicína pro praxi 16:4, pages 215-219.
Crossref
Crossref
Bradley LeechJanet SchlossAmie Steel. (2019) Treatment Interventions for the Management of Intestinal Permeability: A Cross-Sectional Survey of Complementary and Integrative Medicine Practitioners. The Journal of Alternative and Complementary Medicine 25:6, pages 623-636.
Crossref
Crossref
Felix Knauf, J. Richard Brewer & Richard A. Flavell. (2019) Immunity, microbiota and kidney disease. Nature Reviews Nephrology 15:5, pages 263-274.
Crossref
Crossref
Xiang Meng, Hao-Yue Zhou, Hui-Hui Shen, Eniya Lufumpa, Xiao-Mei Li, Biao Guo & Bao-Zhu Li. (2019) Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity. Autoimmunity Reviews 18:5, pages 455-475.
Crossref
Crossref
Heather Catt, Dyfrig Hughes, Jamie J. Kirkham & Keith Bodger. (2019) Systematic review: outcomes and adverse events from randomised trials in Crohn's disease. Alimentary Pharmacology & Therapeutics 49:8, pages 978-996.
Crossref
Crossref
Pablo Alagón Fernández del Campo, Alejandro De Orta Pando, Juan Ignacio Straface, José Ricardo López Vega, Diego Toledo Plata, Sebastian Felipe Niezen Lugo, Diego Alvarez Hernández, Tomás Barrientos Fortes, Laila Gutiérrez–Kobeh, Sandra Georgina Solano-Gálvez & Rosalino Vázquez-López. (2019) The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases. Medical Sciences 7:2, pages 33.
Crossref
Crossref
Abhijit Banik, Suman Kumar Halder, Chandradipa Ghosh & Keshab Chandra Mondal. 2019. Recent Advancement in White Biotechnology Through Fungi. Recent Advancement in White Biotechnology Through Fungi
101
117
.
Kai Jia, Xin Tong, Rong Wang & Xin Song. (2018) The clinical effects of probiotics for inflammatory bowel disease. Medicine 97:51, pages e13792.
Crossref
Crossref
Bradley Leech, Janet Schloss & Amie Steel. (2018) Investigation into complementary and integrative medicine practitioners' clinical experience of intestinal permeability: A cross-sectional survey. Complementary Therapies in Clinical Practice 31, pages 200-209.
Crossref
Crossref
Mahboube Ganji‐Arjenaki & Mahmoud Rafieian‐Kopaei. (2017) Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. Journal of Cellular Physiology 233:3, pages 2091-2103.
Crossref
Crossref
Michael RohrChandrakala Aluganti NarasimhuluDhara SharmaMitsushita DoomraAladdin RiadSaleh NaserSampath Parthasarathy. (2018) Inflammatory Diseases of the Gut. Journal of Medicinal Food 21:2, pages 113-126.
Crossref
Crossref
Alyssa M. Parian, Gerard E. Mullin, Jost Langhorst & Amy C. Brown. 2018. Integrative Medicine. Integrative Medicine
501
516.e8
.
Bryan Tungland. 2018. Human Microbiota in Health and Disease. Human Microbiota in Health and Disease
197
288
.
Bincy P. Abraham & Eamonn M.M. Quigley. (2017) Probiotics in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 46:4, pages 769-782.
Crossref
Crossref
Mariana Grancieri, Neuza Maria Brunoro Costa, Maria das Graças Vaz Tostes, Daniela Silva de Oliveira, Louisiane de Carvalho Nunes, Letícia de Nadai Marcon, Thaísa Agrizzi Veridiano & Mirelle Lomar Viana. (2017) Yacon flour (Smallanthus sonchifolius) attenuates intestinal morbidity in rats with colon cancer. Journal of Functional Foods 37, pages 666-675.
Crossref
Crossref
Alyssa Parian. 2017. Integrating Nutrition Into Practice. Integrating Nutrition Into Practice
347
374
.
Chloé Terciolo, Aurélie Dobric, Mehdi Ouaissi, Carole Siret, Gilles Breuzard, Françoise Silvy, Bastien Marchiori, Sébastien Germain, Renaté Bonier, Adel Hama, Roisin Owens, Dominique Lombardo, Véronique Rigot & Frédéric André. (2017) Saccharomyces boulardii CNCM I-745 Restores intestinal Barrier Integrity by Regulation of E-cadherin Recycling. Journal of Crohn's and Colitis 11:8, pages 999-1010.
Crossref
Crossref
Ann E. Slingerland, Zaker Schwabkey, Diana H. Wiesnoski & Robert R. Jenq. (2017) Clinical Evidence for the Microbiome in Inflammatory Diseases. Frontiers in Immunology 8.
Crossref
Crossref
Alastair Forbes, Johanna Escher, Xavier Hébuterne, Stanisław Kłęk, Zeljko Krznaric, Stéphane Schneider, Raanan Shamir, Kalina Stardelova, Nicolette Wierdsma, Anthony E. Wiskin & Stephan C. Bischoff. (2017) ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clinical Nutrition 36:2, pages 321-347.
Crossref
Crossref
Tiziana Larussa, Maria Imeneo & Francesco Luzza. (2017) Potential role of nutraceutical compounds in inflammatory bowel disease. World Journal of Gastroenterology 23:14, pages 2483.
Crossref
Crossref
Lauren E. Hudson, Sarah E. Anderson, Anita H. Corbett & Tracey J. Lamb. (2017) Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clinical Microbiology Reviews 30:1, pages 191-231.
Crossref
Crossref
K.I. Kroeker & C. Lu. 2017. The Microbiota in Gastrointestinal Pathophysiology. The Microbiota in Gastrointestinal Pathophysiology
331
341
.
L.V. McFarland. 2017. The Microbiota in Gastrointestinal Pathophysiology. The Microbiota in Gastrointestinal Pathophysiology
145
164
.
Yu Qi Qiao, Chen Wen Cai & Zhi Hua Ran. (2017) Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered. Journal of Digestive Diseases 17:12, pages 800-810.
Crossref
Crossref
A Shukla, P Gaur & A Aggarwal. (2016) Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis. Clinical and Experimental Immunology 185:3, pages 301-308.
Crossref
Crossref
Byoungjin Park, Hye‐Ree Lee & Yong‐Jae Lee. (2016) Alcoholic liver disease: focus on prodromal gut health. Journal of Digestive Diseases 17:8, pages 493-500.
Crossref
Crossref
Silvia Ferolla, Cláudia Couto, Luciana Costa-Silva, Geyza Armiliato, Cristiano Pereira, Flaviano Martins, Maria Ferrari, Eduardo Vilela, Henrique Torres, Aloísio Cunha & Teresa Ferrari. (2016) Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients 8:7, pages 397.
Crossref
Crossref
Alberto Bravo-Blas, Hannah Wessel & Simon Milling. (2016) Microbiota and arthritis. Current Opinion in Rheumatology 28:2, pages 161-167.
Crossref
Crossref
Rosario Barone, Francesca Rappa, Filippo Macaluso, Celeste Caruso Bavisotto, Claudia Sangiorgi, Gaia Di Paola, Giovanni Tomasello, Valentina Di Felice, Vito Marcianò, Felicia Farina, Giovanni Zummo, Everly Conway de Macario, Alberto J.L. Macario, Massimo Cocchi, Francesco Cappello & Antonella Marino Gammazza. (2016) Alcoholic Liver Disease: A Mouse Model Reveals Protection by Lactobacillus fermentum. Clinical and Translational Gastroenterology 7:1, pages e138.
Crossref
Crossref
Davood Maleki, Aziz Homayouni, Leila Khalili & Babak Golkhalkhali. 2016. Probiotics, Prebiotics, and Synbiotics. Probiotics, Prebiotics, and Synbiotics
781
791
.
Bincy P. Abraham & Eamonn M. M. Quigley. 2016. Nutritional Management of Inflammatory Bowel Diseases. Nutritional Management of Inflammatory Bowel Diseases
131
147
.
F.C.P. Tiago, B.A.A. Porto, N.S. Ribeiro, L.M.C. Moreira, R.M.E. Arantes, A.T. Vieira, M.M. Teixeira, S.V. Generoso, V.N. Nascimento, F.S. Martins & J.R. Nicoli. (2015) Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease. Beneficial Microbes 6:6, pages 807-816.
Crossref
Crossref
Mario Guslandi. (2015) Role of Probiotics in Crohn’s Disease and in Pouchitis. Journal of Clinical Gastroenterology 49:Supplement 1, pages S46-S49.
Crossref
Crossref
Shaoping WuSonia YoonYong-Guo ZhangRong LuYinglin XiaJiandi WanElaine O. Petrof, Erika C. Claud, Di ChenJun Sun. (2015) Vitamin D receptor pathway is required for probiotic protection in colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 309:5, pages G341-G349.
Crossref
Crossref
Alyssa ParianMDMD. 2015. Integrative Nutrition Therapy. Integrative Nutrition Therapy
347
374
.
Alyssa M. Parian, Berkeley N. Limketkai, Neha D. Shah & Gerard E. Mullin. (2015) Nutraceutical Supplements for Inflammatory Bowel Disease. Nutrition in Clinical Practice 30:4, pages 551-558.
Crossref
Crossref
Lauren E. Ritchie, Stella S. Taddeo, Brad R. Weeks, Florence Lima, Susan A. Bloomfield, M. Andrea Azcarate-Peril, Sara R. Zwart, Scott M. Smith & Nancy D. Turner. (2015) Space Environmental Factor Impacts upon Murine Colon Microbiota and Mucosal Homeostasis. PLOS ONE 10:6, pages e0125792.
Crossref
Crossref
Emanuelle Bellaguarda & Eugene B. Chang. (2015) IBD and the Gut Microbiota—from Bench to Personalized Medicine. Current Gastroenterology Reports 17:4.
Crossref
Crossref
Lauren E. Ritchie, Joseph M. Sturino, Raymond J. Carroll, Lloyd W. Rooney, M. Andrea Azcarate-Peril & Nancy D. Turner. (2015) Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis. FEMS Microbiology Ecology 91:3.
Crossref
Crossref
M. Bürger, K. Lange & A. Stallmach. (2015) Intestinales Mikrobiom und chronisch-entzündliche Darmerkrankungen: Feindschaft oder Freundschaft?Intestinal microbiome in inflammatory bowel disease: enemies or friends?. Der Gastroenterologe 10:2, pages 87-101.
Crossref
Crossref
Juliana Costa Liboredo, Eduardo Garcia Vilela, Maria de Lourdes de Abreu Ferrari, Agnaldo Soares Lima & Maria Isabel Toulson Davisson Correia. (2013) Nutrition Status and Intestinal Permeability in Patients Eligible for Liver Transplantation. Journal of Parenteral and Enteral Nutrition 39:2, pages 163-170.
Crossref
Crossref
S.D.A. Elian, E.L.S. Souza, A.T. Vieira, M.M. Teixeira, R.M.E. Arantes, J.R. Nicoli & F.S. Martins. (2015) Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease. Beneficial Microbes 6:3, pages 277-286.
Crossref
Crossref
Andrea Michielan & Renata D’Incà. (2015) Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators of Inflammation 2015, pages 1-10.
Crossref
Crossref
Stephan C Bischoff, Giovanni Barbara, Wim Buurman, Theo Ockhuizen, Jörg-Dieter Schulzke, Matteo Serino, Herbert Tilg, Alastair Watson & Jerry M Wells. (2014) Intestinal permeability – a new target for disease prevention and therapy. BMC Gastroenterology 14:1.
Crossref
Crossref
Priscilla F. C. Justino, Luis F. M. Melo, Andre F. Nogueira, Jose V. G. Costa, Luara M. N. Silva, Cecila M. Santos, Walber O. Mendes, Marina R. Costa, Alvaro X. Franco, Aldo A. Lima, Ronaldo A. Ribeiro, Marcellus H. L. P. Souza & Pedro M. G. Soares. (2014)
Treatment with
Saccharomyces boulardii
reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice
. British Journal of Nutrition 111:9, pages 1611-1621.
Crossref
Crossref
Alexandre Lages Savassi-Rocha, Marco Túlio Costa Diniz, Eduardo Garcia Vilela, Maria de Fátima Haueisen Sander Diniz, Soraya Rodrigues de Almeida Sanches, Aloísio Sales da Cunha, Maria de Lourdes de Abreu Ferrari, Henrique Oswaldo da Gama Torres, Bruno Antonio Maciente, Gabriela Santana Ataliba, Paloma Maciel Araújo, Taciana Bretas Guerra & Inara Kellen Fonseca Balbino. (2013) Changes in Intestinal Permeability after Roux-en-Y Gastric Bypass. Obesity Surgery 24:2, pages 184-190.
Crossref
Crossref
Rok Orel. (2014) Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World Journal of Gastroenterology 20:33, pages 11505.
Crossref
Crossref
I.W. FongI. W. Fong. 2014. The Role of Microbes in Common Non-Infectious Diseases. The Role of Microbes in Common Non-Infectious Diseases
29
57
.
Susan Mikolaitis, Prachi Chakradeo & Ece Mutlu. 2013. Probiotics and Prebiotics in Food, Nutrition and Health. Probiotics and Prebiotics in Food, Nutrition and Health
410
429
.
Arnaud Bourreille, Guillaume Cadiot, Gérard Le Dreau, David Laharie, Laurent Beaugerie, Jean–Louis Dupas, Philippe Marteau, Patrick Rampal, Dominique Moyse, Ashraf Saleh, Marie–Emmanuelle Le Guern & Jean–Paul Galmiche. (2013) Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease. Clinical Gastroenterology and Hepatology 11:8, pages 982-987.
Crossref
Crossref
Saskia van Hemert, Jurre Verwer & Burkhard Schütz. (2013) Clinical Studies Evaluating Effects of Probiotics on Parameters of Intestinal Barrier Function. Advances in Microbiology 03:02, pages 212-221.
Crossref
Crossref
Alexander SUVOROV. (2013) Gut Microbiota, Probiotics, and Human Health. Bioscience of Microbiota, Food and Health 32:3, pages 81-91.
Crossref
Crossref
Franco Scaldaferri, Viviana Gerardi, Loris Riccardo Lopetuso, Fabio Del Zompo, Francesca Mangiola, Ivo Boškoski, Giovanni Bruno, Valentina Petito, Lucrezia Laterza, Giovanni Cammarota, Eleonora Gaetani, Alessandro Sgambato & Antonio Gasbarrini. (2013) Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility. BioMed Research International 2013, pages 1-9.
Crossref
Crossref
U Daniluk, M Alifier & M Kaczmarski. (2012) Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract. Advances in Medical Sciences 57:2, pages 175-182.
Crossref
Crossref
Richard Fedorak & Denny Demeria. (2012) Probiotic Bacteria in the Prevention and the Treatment of Inflammatory Bowel Disease. Gastroenterology Clinics of North America 41:4, pages 821-842.
Crossref
Crossref
Radu M. Nanau & Manuela G. Neuman. (2012) Nutritional and Probiotic Supplementation in Colitis Models. Digestive Diseases and Sciences 57:11, pages 2786-2810.
Crossref
Crossref
Franco Scaldaferri, Marco Pizzoferrato, Viviana Gerardi, Loris Lopetuso & Antonio Gasbarrini. (2012) The Gut Barrier. Journal of Clinical Gastroenterology 46, pages S12-S17.
Crossref
Crossref
Gabriele Capurso, Giulia Zerboni, Marianna Signoretti, Roberto Valente, Serena Stigliano, Matteo Piciucchi & Gianfranco Delle Fave. (2012) Role of the Gut Barrier in Acute Pancreatitis. Journal of Clinical Gastroenterology 46, pages S46-S51.
Crossref
Crossref
Aziz Homayouni, Laleh Payahoo & Aslan Azizi. (2012) Effects of Probiotics on Lipid Profile: A Review. American Journal of Food Technology 7:5, pages 251-265.
Crossref
Crossref
Daisy Jonkers, John Penders, Ad Masclee & Marieke Pierik. (2012) Probiotics in the Management of Inflammatory Bowel Disease. Drugs 72:6, pages 803-823.
Crossref
Crossref
M Rauch & SV Lynch. (2012) The potential for probiotic manipulation of the gastrointestinal microbiome. Current Opinion in Biotechnology 23:2, pages 192-201.
Crossref
Crossref
Theodoros Kelesidis & Charalabos Pothoulakis. (2011)
Efficacy and safety of the probiotic
Saccharomyces boulardii
for the prevention and therapy of gastrointestinal disorders
. Therapeutic Advances in Gastroenterology 5:2, pages 111-125.
Crossref
Crossref
Jürgen Stein & Axel Dignaß. (2012) Prävention und Therapie von entzündlichen Magen‐/Darm‐Erkrankungen. Pharmazie in unserer Zeit 41:2, pages 123-133.
Crossref
Crossref
Corene Humphreys. 2012. Textbook of Natural Medicine. Textbook of Natural Medicine
169
178
.
Leo Galland. 2012. Integrative Medicine. Integrative Medicine
464
474.e5
.
Bartolomeus Joannes Meijer & Levinus Albert Dieleman. (2011) Probiotics in the Treatment of Human Inflammatory Bowel Diseases. Journal of Clinical Gastroenterology 45, pages S139-S144.
Crossref
Crossref
Seong‐Joon Koh & Joo Sung Kim. (2011) Prebiotics: Germinated barley foodstuff for the prevention of colitis‐associated colon cancer?. Journal of Gastroenterology and Hepatology 26:8, pages 1219-1220.
Crossref
Crossref
Simone V. Generoso, Mirelle L. Viana, Rosana G. Santos, Rosa M. E. Arantes, Flaviano S. Martins, Jacques R. Nicoli, José A. N. Machado, Maria Isabel T. D. Correia & Valbert N. Cardoso. (2010) Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. European Journal of Nutrition 50:4, pages 261-269.
Crossref
Crossref
C. Grangette. (2011) Probiotiques et régulation de la réponse immunitaire: impact sur les maladies allergiques et les maladies inflammatoires intestinalesProbiotics and immune response regulation: allergics diseases and guts inflammations effects. Phytothérapie 9:2, pages 93-99.
Crossref
Crossref
Yutaka Nakashimada, Atsuko Michinaka, Kentaro Watanabe, Naomichi Nishio & Toshio Fujii. (2011) Brewer's yeast cell wall affects microbiota composition and decreases Bacteroides fragilis populations in an anaerobic gut intestinal model. Journal of Bioscience and Bioengineering 111:2, pages 178-184.
Crossref
Crossref
I. Fliss, R. Hammami & C. Le Lay. 2011. Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation. Protective Cultures, Antimicrobial Metabolites and Bacteriophages for Food and Beverage Biopreservation
240
263
.
Sonia S. Yoon & Jun Sun. (2011) Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways. Gastroenterology Research and Practice 2011, pages 1-16.
Crossref
Crossref
Saʼad Y. Salim & Johan D. Söderholm. (2011) Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflammatory Bowel Diseases 17:1, pages 362-381.
Crossref
Crossref
T. Iannitti & B. Palmieri. (2010) Therapeutical use of probiotic formulations in clinical practice. Clinical Nutrition 29:6, pages 701-725.
Crossref
Crossref
KATHERINE JENKS, SIMON STEBBINGS, JEREMY BURTON, MICHAEL SCHULTZ, PETER HERBISON & JOHN HIGHTON. (2010) Probiotic Therapy for the Treatment of Spondyloarthritis: A Randomized Controlled Trial. The Journal of Rheumatology 37:10, pages 2118-2125.
Crossref
Crossref
Marcel Roberfroid, Glenn R. Gibson, Lesley Hoyles, Anne L. McCartney, Robert Rastall, Ian Rowland, Danielle Wolvers, Bernhard Watzl, Hania Szajewska, Bernd Stahl, Francisco Guarner, Frederique Respondek, Kevin Whelan, Veronique Coxam, Marie-Jeanne Davicco, Laurent Léotoing, Yohann Wittrant, Nathalie M. Delzenne, Patrice D. Cani, Audrey M. Neyrinck & Agnes Meheust. (2010) Prebiotic effects: metabolic and health benefits. British Journal of Nutrition 104:S2, pages S1-S63.
Crossref
Crossref
Saloomeh Moslehi-Jenabian, Line Lindegaard & Lene Jespersen. (2010) Beneficial Effects of Probiotic and Food Borne Yeasts on Human Health. Nutrients 2:4, pages 449-473.
Crossref
Crossref
Sang Kil LeeHyo Jong KimSung Gil Chi. (2010) Saccharomyces boulardii Reduced Intestinal Inflammation in Mice Model of 2,4,6-trinitrobencene Sulfonic Acid Induced Colitis: Based on Microarray. The Korean Journal of Gastroenterology 55:1, pages 33.
Crossref
Crossref
Caroline Reiff & Denise Kelly. (2010) Inflammatory bowel disease, gut bacteria and probiotic therapy. International Journal of Medical Microbiology 300:1, pages 25-33.
Crossref
Crossref
Roland Bücker, Michael Schumann, Salah Amasheh & Jörg-Dieter Schulzke. 2010.
195
227
.
Ulrike Lodemann. 2010. Bioactive Foods in Promoting Health. Bioactive Foods in Promoting Health
303
333
.
C. Reiff, M. Delday, G. Rucklidge, M. Reid, G. Duncan, S. Wohlgemuth, G. Hörmannsperger, G. Loh, M. Blaut, E. Collie-Duguid, D. Haller & D. Kelly. (2009) Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 15:11, pages 1721-1736.
Crossref
Crossref
O. Goulet. (2009) Un probiotique pas comme les autres : d’une histoire tropicale à des propriétés biologiques et des effets cliniques prouvés. Journal de Pédiatrie et de Puériculture 22:6, pages 269-272.
Crossref
Crossref
Rudolf Mennigen & Matthias Bruewer. (2009) Effect of Probiotics on Intestinal Barrier Function. Annals of the New York Academy of Sciences 1165:1, pages 183-189.
Crossref
Crossref
E.G. Vilela, H.O.G. Torres, M.L.A. Ferrari, A.S. Lima & A.S. Cunha. (2008) Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Brazilian Journal of Medical and Biological Research 41:12, pages 1105-1109.
Crossref
Crossref